FDA Inspection 1157271 — Kaiser Permanente Center For Reproductive Health
The FDA completed an inspection of Kaiser Permanente Center For Reproductive Health on Nov 17, 2021 in Sacramento, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 17, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Sacramento, CA (United States)